About Index Trending news
Top 50 Pricing
Critical Outcome Technologies

Critical Outcome Technologies

Work at Critical Outcome Technologies? Add yourself to this profile

Critical Outcome Technologies

Multiple clinical trials planned for COTI-2, our p53-dependent, potential breakthrough treatment for many cancers. | Listed on the TSX Venture Exchange as COT.


Alexa global traffic share

Twitter followers

Latest funding Show all
Venture capital
Post-IPO equity

Unknown size


No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Critical Outcome Technologies makes some noise.